New frontiers in cardiology: drug-eluting stents: Part II

Circulation. 2003 May 13;107(18):2383-9. doi: 10.1161/01.CIR.0000069331.67148.2F.
No abstract available

Publication types

  • Review

MeSH terms

  • Anticoagulants / administration & dosage
  • Anticoagulants / therapeutic use
  • Clinical Trials as Topic
  • Combined Modality Therapy
  • Coronary Angiography
  • Estradiol / administration & dosage
  • Estradiol / therapeutic use
  • Graft Occlusion, Vascular / diagnostic imaging
  • Graft Occlusion, Vascular / prevention & control*
  • Growth Inhibitors / administration & dosage
  • Growth Inhibitors / therapeutic use
  • Humans
  • Matrix Metalloproteinase Inhibitors
  • Patient Selection
  • Protease Inhibitors / administration & dosage
  • Protease Inhibitors / therapeutic use
  • Stents*

Substances

  • Anticoagulants
  • Growth Inhibitors
  • Matrix Metalloproteinase Inhibitors
  • Protease Inhibitors
  • Estradiol